Pipeline
Our clinical and commercialization focus is on novel therapeutic strategies to noninvasively monitor and disrupt proinflammatory interactions of chemokines and prevent or reverse inflammation associated with a broad array of human diseases including cardiovascular disease, pulmonary inflammation, and other acute and chronic inflammatory disorders.
IND Filings
